EchoGo® Heart Failure vs EchoGo Pro
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These two tools are highly comparable in their underlying technology and vendor, both being FDA-cleared, AI-powered cloud solutions from Ultromics for echocardiogram analysis. However, they address distinct clinical needs: EchoGo® Heart Failure focuses on detecting HFpEF from routine echocardiograms, while EchoGo Pro specializes in automating stress echocardiography analysis for coronary artery disease diagnosis. Therefore, they serve complementary rather than directly competing purposes within cardiology.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGo Heart Failure is an AI platform that analyzes routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF). EchoGo Pro is an AI-powered cloud solution that automates stress echocardiography analysis to improve the diagnosis of Coronary Artery Disease (CAD).
EchoGo Heart Failure analyzes routine echocardiogram video clips, specifically a single apical 4-chamber view, to detect HFpEF. EchoGo Pro automates the analysis of stress echocardiography to identify coronary artery disease.
EchoGo Heart Failure provides insights to support clinical decisions within 20 minutes. EchoGo Pro delivers near-instant, comprehensive reports for coronary artery disease diagnosis.
EchoGo Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For EchoGo Pro, reimbursement codes are available for related EchoGo products, such as CPT 0932T for EchoGo Heart Failure and NTAP XXE2X19 for inpatient settings.
EchoGo Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection. EchoGo Pro is stated to improve diagnostic accuracy and reduce misdiagnosis for CAD, with one trial showing 92% accuracy in diagnosing CAD.
EchoGo Heart Failure is designed for Cardiology, Emergency Medicine, and Internal Medicine. EchoGo Pro is primarily targeted towards Cardiology.